All In MedTech

Device Trial Radar · NCT06567795

PRimary IndividualiZed Evaluation of Cardiovascular Events in Patients With Diabetes Mellitus Using hemoTAG

Prospective, Multi-center, Longitudinal, Study for PRimary IndividualiZed Evaluation of Cardiovascular Events in Patients With Diabetes Mellitus Using hemoTAG

Last checked: Nov 19, 2026Latest source record: Aug 23, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

189

Planned (sponsor's estimate)

Start

Mar 14, 2024

Primary completion

Mar 18, 2026

Study completion Mar 18, 2027

Sponsor

Lead sponsor
Aventusoft, LLC.Not on our public-company list
Sponsor type
Industry
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
First posted
Aug 23, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the proportion of diabetic mellitus patients with CV events as measured by HEMOTAG.

Conditions

  • Diabetes Mellitus Type 2
  • Cardiovascular Diseases
  • Coronary Artery Disease
  • Cerebrovascular Disease
  • Peripheral Artery Disease

Interventions

  • HemotagDevice

    Hemotag non-invasive medical device is used to see cardiac function for DM2 patients at-home for 30 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To evaluate the proportion of diabetic mellitus patients with cardiovascular events as identified by HEMOTAG measurements over a 12 month duration.Time frame: 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Metabolic Research Institute, Inc

    West Palm Beach, Florida · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.